![](/img/cover-not-exists.png)
Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving myelosuppressive chemotherapy
Desai, Kalpna, Misra, Priya, Kher, Sanyukta, Shah, NirmeshVolume:
7
Language:
english
Journal:
Experimental Hematology & Oncology
DOI:
10.1186/s40164-018-0114-9
Date:
December, 2018
File:
PDF, 1.01 MB
english, 2018